Magic mushroom therapy targets cancer fear in remission patients

NCT ID NCT06430541

Recruiting now Symptom relief Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can reduce fear of cancer returning in 20 women with early-stage breast or ovarian cancer who are currently in remission. Participants receive a moderately high dose of psilocybin in a supportive setting, followed by integration sessions. The study measures changes in fear, anxiety, depression, and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER OVARIAN CANCER

Contacts and locations

Locations

Outpatient CTRC
RECRUITING

Aurora, Colorado, 80045, United States
University of Colorado Cancer Center
RECRUITING

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.